微泡
医学
旁分泌信号
再生医学
再生(生物学)
子宫内膜异位症
干细胞
免疫系统
保持生育能力
癌症研究
免疫学
病理
生物
内科学
细胞生物学
受体
小RNA
生物化学
生育率
人口
环境卫生
基因
作者
Zheng Xu,Dan Zhao,Yang Liu,Ye Jin,Tianjia Liu,Hui‐Jing Li,Da Liu
标识
DOI:10.1016/j.biopha.2023.115739
摘要
There are many gynecological diseases, among which breast cancer (BC), cervical cancer (CC), endometriosis (EMs), and polycystic ovary syndrome (PCOS) are common and difficult to cure. Stem cells (SCs) are a focus of regenerative medicine. They are commonly used to treat organ damage and difficult diseases because of their potential for self-renewal and multidirectional differentiation. SCs are also commonly used for difficult-to-treat gynecological diseases because of their strong directional differentiation ability with unlimited possibilities, their tendency to adhere to the diseased tissue site, and their use as carriers for drug delivery. SCs can produce exosomes in a paracrine manner. Exosomes can be produced in large quantities and have the advantage of easy storage. Their safety and efficacy are superior to those of SCs, which have considerable potential in gynecological treatment, such as inhibiting endometrial senescence, promoting vascular reconstruction, and improving anti-inflammatory and immune functions. In this paper, we review the mechanisms of the regenerative and anti-inflammatory capacity of SCs and exosomes in incurable gynecological diseases and the current progress in their application in genetic engineering to provide a foundation for further research.
科研通智能强力驱动
Strongly Powered by AbleSci AI